[1]
“Improving the Drug Bioavailability Property of Myricetin through a Structural Monosubstitution Modification Approach: an In-Silico Pharmacokinetics Study”, AJBR, vol. 22, nº 3, p. 347–352, dez. 2019, Acesso em: 6º de junho de 2026. [Online]. Disponível em: https://ojshostng.com/index.php/ajbr/article/view/1335